PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
53 hedge funds and large institutions have $20.7M invested in Pear Therapeutics, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
78% less capital invested
Capital invested by funds: $96.3M → $20.7M (-$75.6M)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.09M | |
| 2 | +$182K | |
| 3 | +$30.7K | |
| 4 |
SG Americas Securities
New York
|
+$15.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$15K |
Top Sellers
| 1 | -$586K | |
| 2 | -$183K | |
| 3 | -$132K | |
| 4 |
PT
Palantir Technologies
Denver,
Colorado
|
-$76.5K |
| 5 |
Jane Street
New York
|
-$53K |